Science at Sanofi

Explore ATS 2026 key sessions on dupilumab, COPD biologics, FeNO biomarkers, and asthma remission. Real-world evidence for HCPs

AAD 2026 post-congress: Complete systemic therapy update. Multi-indication clinical data for inflammatory dermatological conditions.

The United in Rare: Advancing LSDs Care across Asia event was held on the 22^nd to 23^rd November 2025 in Bangkok, Thailand. The event aimed to provide a platform for experts across Thailand, Malaysia, Singapore, Taiwan, South Korea and India to share their experiences in management of LSDs by discussing challenges cases and best practices to improve diagnosis and treatment pathways for LSDs.

The programme brought together international and local experts to discuss the evolving understanding of Type 2 inflammation in atopic dermatitis, with a focus on IL-4 and IL-13, disease modification, and the importance of early intervention across different patient populations. 

The United in Rare: Advancing LSDs Care across Asia event was held on the 22nd to 23rd November 2025 in Bangkok, Thailand. The event aimed to provide a platform for experts across Thailand, Malaysia, Singapore, Taiwan, South Korea and India to share their experiences in management of LSDs by discussing challenges cases and best practices to improve diagnosis and treatment pathways for LSDs.

Access the full recording of the webinar to gain insights on Atopic Dermatitis, Bullous Pemphigoid, and practical applications from leading experts.

Discover the latest breakthroughs in pediatric infectious diseases, focusing on Pertussis, Polio and Hib protection.

Watch now to gain useful update on the latest in COPD diagnosis and management.​

Curated June evidence on atopic dermatitis, organised around the four disease-modification pillars — starting with new data on skin-barrier restoration in children

The United in RARE: Advancing LSDs Care Across Asia meeting was held on 22–23 November 2025 in Bangkok, Thailand, bringing together experts from across Asia to share insights, clinical experiences, and best practices in the diagnosis and management of Gaucher disease and Acid Sphingomyelinase Deficiency (ASMD), with a focus on improving patient identification, treatment access, and long-term outcomes.

SCORE-AD Calculator & Atopic Dermatitis Assessment Tools for Healthcare Professionals. Access validated severity scales including SCORAD, EASI, vIGA-AD, DLQI, and POEM to evaluate disease severity, patient outcomes, and quality of life in one platform.

We're excited to announce OneRare, our streamlined approach to ordering DBS (Dried Blood Spot) kits for rare disease diagnostics. Built on the same trusted testing you know, OneRare introduces an enhanced digital ordering workflow designed to reduce administrative burden and improve turnaround times.

Systematic review shows Beyfortus^® reduces RSV hospitalizations by 83% and ICU admissions by 81% in real-world infant immunization programs.